0000899243-16-011133.txt : 20160106 0000899243-16-011133.hdr.sgml : 20160106 20160106160544 ACCESSION NUMBER: 0000899243-16-011133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160104 FILED AS OF DATE: 20160106 DATE AS OF CHANGE: 20160106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coherus BioSciences, Inc. CENTRAL INDEX KEY: 0001512762 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 273615821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 201 REDWOOD SHORES PARKWAY, SUITE 200 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 649-3530 MAIL ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 201 REDWOOD SHORES PARKWAY, SUITE 200 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: BioGenerics, Inc. DATE OF NAME CHANGE: 20110210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Herman Alan C. CENTRAL INDEX KEY: 0001622080 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36721 FILM NUMBER: 161326854 MAIL ADDRESS: STREET 1: 2225 ROSA VISTA TERRACE CITY: CAMARILLO STATE: CA ZIP: 93012 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-01-04 0 0001512762 Coherus BioSciences, Inc. CHRS 0001622080 Herman Alan C. COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065 0 1 0 0 Chief Scientific Officer Common Stock, $0.0001 par value 2016-01-04 4 S 0 3950 21.4038 D 223915 D Common Stock, $0.0001 par value 2016-01-04 4 S 0 300 22.3567 D 223615 D Common Stock, $0.0001 par value 300164 I By Trust The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. The transaction was executed in multiple trades in prices ranging from $21.06 to $21.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. The transaction was executed in multiple trades in prices ranging from $22.30 to $22.44, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. These shares are held by the Herman Trust, dated March 16, 2001, of which Reporting Person is a co trustee. /s/ Jean-Frederic Viret, as Attorney-in-Fact for Alan C. Herman, Ph.D. 2016-01-06